Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors

Core Viewpoint - Emergent BioSolutions Inc. has appointed John D. Fowler, Jr. to its board of directors, effective March 1, 2026, to support the company's ongoing transformation and strategic priorities [1][2]. Group 1: Appointment Details - John D. Fowler, Jr. brings over 30 years of leadership experience in healthcare and financial services [1][2]. - He will serve on the Audit and Finance Committee of the board [1]. - Dr. Zsolt Harsanyi, chairman of the board, emphasized the importance of Fowler's experience in driving long-term shareholder value during the company's turnaround [2]. Group 2: Background of John D. Fowler, Jr. - Fowler is currently the chair of the board of trustees of the University of Virginia Darden School Foundation [2]. - He has held senior leadership roles at Wells Fargo Securities, Deutsche Bank, JPMorgan, and Salomon Brothers [3]. - His previous positions include president of Large Scale Biology Corporation and managing partner of Baycrest Capital [3]. Group 3: Educational Background - Fowler earned a Juris Doctor degree from the University of Virginia School of Law, an MBA from the University of Virginia Darden School of Business, and a Bachelor of Arts in History from the University of Virginia [4]. Group 4: Company Mission - Emergent BioSolutions has been dedicated to protecting public health for over 25 years, providing solutions for health threats such as smallpox, Ebola, and opioid overdoses [5].